Evidence map›Paper›PMID 40263635›Full record

ArticleBone marrow transplantation2025

Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT).

Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Jorge Ramos-Perez, Deepa Jeyakumar, Benjamin J Lee, Jean Doh, Shawn Griffin, Matthew Nguyen, Ramy M Hanna, Minh-Ha Tran and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Piyatida ChumnumsiriwathHematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, USA.
Pongthep VittayawacharinHematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, USA.
Jorge Ramos-PerezHematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, USA.
Deepa JeyakumarHematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, USA.
Benjamin J LeeDepartment of Pharmacy, University of California Irvine, Orange, CA, USA.ORCID http://orcid.org/0000-0002-1678-1345
Jean DohDepartment of Pharmacy, University of California Irvine, Orange, CA, USA.
Shawn GriffinDepartment of Pharmacy, University of California Irvine, Orange, CA, USA.ORCID http://orcid.org/0000-0002-3818-2490
Matthew NguyenUniversity of California Irvine School of Medicine, Irvine, USA.
Ramy M HannaDivision of Nephrology, Hypertension and Kidney Transplantation, University of California, Irvine School of Medicine, Orange, CA, USA.
Minh-Ha TranDepartment of Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine, Irvine, CA, USA.
Piyanuch KongtimHematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, USA.
Stefan O CiureaHematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA, USA. sciurea@hs.uci.edu.ORCID http://orcid.org/0000-0001-8597-3271

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
NCI NIH HHS P30 CA062203
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40263635
PMCPMC12577200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.